|
Market Closed -
NYSE
16:00:02 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 49.48 USD | -0.20% |
|
-1.83% | +21.87% |
| 07-30 | CONMED Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| 07-30 | CONMED Corporation, Q2 2026 Earnings Call, Jul 29, 2026 |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,485 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 18.11% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 2,226 | 2,123 | 2,004 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | 8.53% | -4.65% | -5.59% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 12.8x | 11x | 10.4x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.3x | 1.14x | 1x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.7x | 1.56x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 1.09x | 1.04x | 0.98x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.63x | 1.48x | 1.33x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 7.95x | 7.2x | 6.38x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 10.4x | 9.37x | 7.99x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 10.4x | 12.9x | 12x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 9.61% | 7.75% | 8.33% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.88 | 4.49 | 4.79 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,366 | 1,434 | 1,511 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 280 | 295 | 314 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 214 | 226.6 | 250.9 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 116.7 | 135 | 142.6 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 741.5 | 637.9 | 519.2 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 49.58 | 49.58 | 49.58 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 29,951 | - | - |
| Announcement Date | 1/26/22 | 2/2/23 | 1/31/24 | 2/5/25 | 1/28/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 12.78x | 1.63x | 7.95x | -.--% | 1.48B | |
| 31.49x | 4.25x | 16.45x | 2.34% | 190B | |
| 20.55x | 3.56x | 12.51x | 3.28% | 116B | |
| 18.28x | 0.21x | 13.13x | 0.72% | 63.71B | |
| 32.06x | 8.01x | 20.38x | 1.24% | 55.13B | |
| 35.17x | 3.38x | 11.56x | 2.16% | 49.41B | |
| 35.89x | 6.31x | 19.82x | -.--% | 33.79B | |
| 44.07x | 1.3x | 11.84x | 0.17% | 30.74B | |
| 40.97x | 7.18x | 25.76x | 0.26% | 24.73B | |
| 20.49x | 3.09x | 11.59x | 1.43% | 23.85B | |
| Average | 29.18x | 3.89x | 15.10x | 1.16% | 58.88B | |
| Weighted average by Cap. | 29.08x | 3.99x | 15.40x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
